방광암 시장은 2023-2028년간 24억 4,960만 달러 확대되고, 11.4%의 연평균 복합 성장률(CAGR)로 확대될 전망입니다. 이 보고서는 방광암 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.
현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 방광암 발병률 증가, 노인 인구 증가, 방광암 인식 제고 캠페인 등이 방광암 시장을 주도하고 있습니다.
| 시장 범위 |
| 기준 연도 |
2024년 |
| 종료 연도 |
2028년 |
| 예측 기간 |
2024-2028년 |
| 성장 모멘텀 |
가속 |
| 전년 대비(2024년) |
17.8% |
| CAGR |
11.4% |
| 증분 금액 |
24억 4,960만 달러 |
이 보고서는 향후 몇 년동안 방광암 시장 성장을 주도할 주요 요인 중 하나로 신약의 승인을 꼽았습니다. 또한, 비침습적 진단 도구의 채택과 아시아 지역의 의료 관광 산업의 성장은 시장 수요를 크게 증가시킬 것으로 예상했습니다.
목차
제1장 주요 요약
제2장 Technavio의 분석
- 가격 민감도, 수명주기, 고객 구입 바스켓, 채택 비율, 구입 기준 분석
- 인풋의 중요성과 차별화 요인
- 혼란 요인
- 성장 촉진요인과 과제의 영향
제3장 시장 구도
제4장 시장 규모
- 시장의 정의
- 시장 부문 분석
- 시장 규모, 2023년
- 시장 전망, 2023-2028년
제5장 시장 규모 실적
- 세계의 방광암 시장, 2018-2022년
- 질환 유형별 분석, 2018-2022년
- 약제 클래스별 분석, 2018-2022년
- 지역별 분석, 2018-2022년
- 국가별 분석, 2018-2022년
제6장 정성 분석
제7장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁 위협
- 시장 현황
제8장 시장 세분화 : 질환 유형별
- 시장 부문
- 비교 : 질환 유형별
- 이동 상피암 : 시장 규모와 예측, 2023-2028년
- 기타 : 시장 규모와 예측, 2023-2028년
- 시장 기회 : 질환 유형별
제9장 시장 세분화 : 약제 클래스별
- 시장 부문
- 비교 약제 클래스별
- 면역치료제 : 시장 규모와 예측, 2023-2028년
- 화학요법제 : 시장 규모와 예측, 2023-2028년
- 표적 치료제 : 시장 규모와 예측, 2023-2028년
- 시장 기회 : 약제 클래스별
제10장 고객 상황
제11장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측, 2023-2028년
- 유럽 : 시장 규모와 예측, 2023-2028년
- 아시아 : 시장 규모와 예측, 2023-2028년
- 세계 기타 지역 : 시장 규모와 예측, 2023-2028년
- 미국 : 시장 규모와 예측, 2023-2028년
- 독일 : 시장 규모와 예측, 2023-2028년
- 일본 : 시장 규모와 예측, 2023-2028년
- 영국 : 시장 규모와 예측, 2023-2028년
- 중국 : 시장 규모와 예측, 2023-2028년
- 캐나다 : 시장 규모와 예측, 2023-2028년
- 프랑스 : 시장 규모와 예측, 2023-2028년
- 인도 : 시장 규모와 예측, 2023-2028년
- 이탈리아 : 시장 규모와 예측, 2023-2028년
- 스페인 : 시장 규모와 예측, 2023-2028년
- 시장 기회 : 지역 상황별
제12장 성장 촉진요인, 과제, 기회 및 성장 억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회와 성장 억제요인
제13장 경쟁 구도
제14장 경쟁 분석
- 기업 개요
- 기업 순위 지수
- 기업의 시장 포지셔닝
- Adaptimmune Therapeutics plc
- Amneal Pharmaceuticals Inc.
- Astellas Pharma Inc.
- AstraZeneca Plc
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- Endo International Plc
- Ferring BV
- Incyte Corp.
- Johnson and Johnson Inc.
- MEDYRA PHARMACEUTICAL
- Merck and Co. Inc.
- Merck KGaA
- Pfizer Inc.
- UroGen Pharma Ltd
제15장 부록
LSH
Bladder Cancer Market 2024-2028
The bladder cancer market is forecasted to grow by USD 2449.6 mn during 2023-2028, accelerating at a CAGR of 11.4% during the forecast period. The report on the bladder cancer market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of bladder cancer, increasing geriatric population, and bladder cancer awareness campaigns.
| Market Scope |
|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 17.8% |
| CAGR | 11.4% |
| Incremental Value | $2449.6 mn |
Technavio's bladder cancer market is segmented as below:
By Disease Type
- Transitional cell carcinoma
- Others
By Drug Class
- Immunotherapy drugs
- Chemotherapy drugs
- Target therapy drugs
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the approval of new drugs as one of the prime reasons driving the bladder cancer market growth during the next few years. Also, adoption of non-invasive diagnostic tools and growth of medical tourism industry in asia will lead to sizable demand in the market.
The report on the bladder cancer market covers the following areas:
- Bladder Cancer Market sizing
- Bladder Cancer Market forecast
- Bladder Cancer Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bladder cancer market vendors that include Adaptimmune Therapeutics plc, Amneal Pharmaceuticals Inc., Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bristol Myers Squibb Co., Eli Lilly and Co., Endo International Plc, Ferring BV, Incyte Corp., Johnson and Johnson Inc., MEDYRA PHARMACEUTICAL, Merck and Co. Inc., Merck KGaA, Nanostics, Pfizer Inc., and UroGen Pharma Ltd. Also, the bladder cancer market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Disease Type
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2023
- 4.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size
- 5.1 Global Bladder Cancer Market 2018 - 2022
- Historic Market Size - Data Table on Global Bladder Cancer Market 2018 - 2022 ($ million)
- 5.2 Disease Type segment analysis 2018 - 2022
- Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
- 5.3 Drug Class segment analysis 2018 - 2022
- Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
- 5.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 5.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
6 Qualitative Analysis
- 6.1 Impact of Artificial Intelligence (AI) on Global Bladder Cancer Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 7.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by Disease Type
- 8.1 Market segments
- Chart on Disease Type - Market share 2023-2028 (%)
- Data Table on Disease Type - Market share 2023-2028 (%)
- 8.2 Comparison by Disease Type
- Chart on Comparison by Disease Type
- Data Table on Comparison by Disease Type
- 8.3 Transitional cell carcinoma - Market size and forecast 2023-2028
- Chart on Transitional cell carcinoma - Market size and forecast 2023-2028 ($ million)
- Data Table on Transitional cell carcinoma - Market size and forecast 2023-2028 ($ million)
- Chart on Transitional cell carcinoma - Year-over-year growth 2023-2028 (%)
- Data Table on Transitional cell carcinoma - Year-over-year growth 2023-2028 (%)
- 8.4 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
- 8.5 Market opportunity by Disease Type
- Market opportunity by Disease Type ($ million)
- Data Table on Market opportunity by Disease Type ($ million)
9 Market Segmentation by Drug Class
- 9.1 Market segments
- Chart on Drug Class - Market share 2023-2028 (%)
- Data Table on Drug Class - Market share 2023-2028 (%)
- 9.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- 9.3 Immunotherapy drugs - Market size and forecast 2023-2028
- Chart on Immunotherapy drugs - Market size and forecast 2023-2028 ($ million)
- Data Table on Immunotherapy drugs - Market size and forecast 2023-2028 ($ million)
- Chart on Immunotherapy drugs - Year-over-year growth 2023-2028 (%)
- Data Table on Immunotherapy drugs - Year-over-year growth 2023-2028 (%)
- 9.4 Chemotherapy drugs - Market size and forecast 2023-2028
- Chart on Chemotherapy drugs - Market size and forecast 2023-2028 ($ million)
- Data Table on Chemotherapy drugs - Market size and forecast 2023-2028 ($ million)
- Chart on Chemotherapy drugs - Year-over-year growth 2023-2028 (%)
- Data Table on Chemotherapy drugs - Year-over-year growth 2023-2028 (%)
- 9.5 Target therapy drugs - Market size and forecast 2023-2028
- Chart on Target therapy drugs - Market size and forecast 2023-2028 ($ million)
- Data Table on Target therapy drugs - Market size and forecast 2023-2028 ($ million)
- Chart on Target therapy drugs - Year-over-year growth 2023-2028 (%)
- Data Table on Target therapy drugs - Year-over-year growth 2023-2028 (%)
- 9.6 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
10 Customer Landscape
- 10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
- 11.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 11.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 11.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 11.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 11.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 11.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 11.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 11.9 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 11.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 11.11 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 11.12 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 11.13 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
- 11.14 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)
- 11.15 Italy - Market size and forecast 2023-2028
- Chart on Italy - Market size and forecast 2023-2028 ($ million)
- Data Table on Italy - Market size and forecast 2023-2028 ($ million)
- Chart on Italy - Year-over-year growth 2023-2028 (%)
- Data Table on Italy - Year-over-year growth 2023-2028 (%)
- 11.16 Spain - Market size and forecast 2023-2028
- Chart on Spain - Market size and forecast 2023-2028 ($ million)
- Data Table on Spain - Market size and forecast 2023-2028 ($ million)
- Chart on Spain - Year-over-year growth 2023-2028 (%)
- Data Table on Spain - Year-over-year growth 2023-2028 (%)
- 11.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
- 12.1 Market drivers
- 12.2 Market challenges
- 12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 12.4 Market opportunities/restraints
13 Competitive Landscape
- 13.1 Overview
- 13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 13.3 Landscape disruption
- Overview on factors of disruption
- 13.4 Industry risks
- Impact of key risks on business
14 Competitive Analysis
- 14.1 Companies profiled
- 14.2 Company ranking index
- 14.3 Market positioning of companies
- Matrix on companies position and classification
- 14.4 Adaptimmune Therapeutics plc
- Adaptimmune Therapeutics plc - Overview
- Adaptimmune Therapeutics plc - Product / Service
- Adaptimmune Therapeutics plc - Key offerings
- SWOT
- 14.5 Amneal Pharmaceuticals Inc.
- Amneal Pharmaceuticals Inc. - Overview
- Amneal Pharmaceuticals Inc. - Business segments
- Amneal Pharmaceuticals Inc. - Key news
- Amneal Pharmaceuticals Inc. - Key offerings
- Amneal Pharmaceuticals Inc. - Segment focus
- SWOT
- 14.6 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings
- SWOT
- 14.7 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
- 14.8 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
- 14.9 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
- 14.10 Endo International Plc
- Endo International Plc - Overview
- Endo International Plc - Business segments
- Endo International Plc - Key news
- Endo International Plc - Key offerings
- Endo International Plc - Segment focus
- SWOT
- 14.11 Ferring BV
- Ferring BV - Overview
- Ferring BV - Product / Service
- Ferring BV - Key news
- Ferring BV - Key offerings
- SWOT
- 14.12 Incyte Corp.
- Incyte Corp. - Overview
- Incyte Corp. - Product / Service
- Incyte Corp. - Key offerings
- SWOT
- 14.13 Johnson and Johnson Inc.
- Johnson and Johnson Inc. - Overview
- Johnson and Johnson Inc. - Business segments
- Johnson and Johnson Inc. - Key news
- Johnson and Johnson Inc. - Key offerings
- Johnson and Johnson Inc. - Segment focus
- SWOT
- 14.14 MEDYRA PHARMACEUTICAL
- MEDYRA PHARMACEUTICAL - Overview
- MEDYRA PHARMACEUTICAL - Product / Service
- MEDYRA PHARMACEUTICAL - Key offerings
- SWOT
- 14.15 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
- 14.16 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
- 14.17 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- 14.18 UroGen Pharma Ltd
- UroGen Pharma Ltd - Overview
- UroGen Pharma Ltd - Product / Service
- UroGen Pharma Ltd - Key offerings
- SWOT
15 Appendix
- 15.1 Scope of the report
- 15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 15.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 15.4 Research methodology
- 15.5 Data procurement
- 15.6 Data validation
- 15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 15.8 Data synthesis
- 15.9 360 degree market analysis
- 360 degree market analysis
- 15.10 List of abbreviations
